Accelerate Diagnostics announces collaboration with Bruker

Accelerate Diagnostics (AXDX) announced the signing of a collaboration and quality agreement with Bruker Corporation (BRKR), the provider of the market-leading MALDI Biotyper system for microbial identification. This agreement enables both companies to validate the use of Accelerate Diagnostics’ Arc system, an innovative, automated positive blood culture sample preparation platform, with Bruker’s MALDI Biotyper sirius instruments and Sepsityper software for subsequent registration in both the US and EMEA markets.